The feature frequencies were plotted in a two-dimensional heatmap, and clustering was performed on the basis of Euclidian distance as a measure of similarity

The feature frequencies were plotted in a two-dimensional heatmap, and clustering was performed on the basis of Euclidian distance as a measure of similarity. The feature analysis revealed a high similarity among individuals with mutated genes of the GPI transamidase complex (mutations and are therefore considered characteristic for the MCAHS disease entity. GPI transamidase formed by PIGT, PIGS, PIGK, and GPAA1.4 Therefore, the presumed molecular function of PIGU is the presentation of the GPI lipid anchor to the transamidase complex in a productive conformation.3 Mutations in three genes of the GPI transamidase complex have been associated with human disease. Severe intellectual disability, global developmental delay, muscular hypotonia, seizures, and cerebellar atrophy were described in individuals with (GPIBD15 [MIM: 617810])5 and mutations (GPIBD7 or multiple congenital anomalies-hypotonia-seizures syndrome 3 [MCAHS3 (MIM: 615398)]);6 deficiency leads to severe global developmental delay, seizures, hypotonia, ataxia, and dysmorphic facial features (GPIBD18 [MIM: 618143]).7 Here, we describe five individuals from three unrelated families with JI051 rare biallelic missense mutations in presenting with global developmental delay, severe-to-profound intellectual disability, muscular hypotonia, seizures, brain anomalies, scoliosis, and mild facial dysmorphism consistent with GPI biosynthesis deficiencies (GPIBDs).8, 9 We provide clinical and functional evidence for a form of a severe autosomal-recessive GPIBD caused by pathogenic mutations in (GenBank: NM_080476.4): c.209T A (p.Ile70Lys), exon 3 in the two affected siblings (P-1 and P-2) of family 1, and c.1149C A (p.Asn383Lys), exon 11 in families 2 and 3 (Figures 1 and ?and2A).2A). Sanger sequencing confirmed biparental inheritance of the variants in all families; pedigrees and genotypes are shown in Physique?1. The variant c.209T A (CADD score 25.9) has not been observed in gnomAD,11 while c.1149C A (CADD score 26.5) has been observed only in a heterozygous state, in individuals from a European populace, and with an allele frequency of JI051 7/277194. Both variants were predicted to be pathogenic by MutationTaster,12 UMD Predictor,13 SIFT,14 and PolyPhen2.14 The exchange of the hydrophobic amino acid isoleucine at position 70 to a JI051 hydrophilic lysine was predicted to cause a conformational change of the first ER luminal domain between TM1 and TM2 (Grantham score 102). The exchange of the amino acid asparagine to lysine at position 383 is also positioned in an ER luminal domain before TM10 (Grantham score 94) (Figures 2B and ?and33C). Open in a separate window Figure?1 Pedigrees of the Families 1, 2, and 3 with the Mutations in Gene and Protein (A) Exon-intron structure and mutational scenery of for the GPI anchoring process, we performed flow cytometry on peripheral blood samples collected in CytoChex blood collection tubes (BCTs). For multicolor flow cytometry, cells were stained with fluorescently labeled antibodies against GPI-APs (CD16, CD24, CD55, and CD59), as well as with fluorescein-labeled proaerolysin (FLAER), which binds to the GPI anchor itself. Use of the?T5 4E10 antibody allowed detection of free GPI anchors.15, 16, 17, 18 Relative reduction of GPI-AP was calculated as a ratio of the staining index (SI) of an affected individual to the SIs of healthy parents and healthy unrelated controls. It is noteworthy that there were only subtle differences in GPI-AP staining between heterozygous carriers of pathogenic mutations (parents) and unrelated healthy controls. As revealed by reduced expression of FLAER, the relative expression of GPI-APs CD16 and CD24 was significantly reduced on granulolcytes compared to controls. But CD55 expression was not significantly altered and CD59 expression was only slightly increased in three out of four individuals with mutations in compared JI051 JI051 to controls. (Physique?3). However, CD55 expression was not altered from that of controls, whereas CD59 expression was higher than that in controls in three out of four individuals with mutations in reduce the function of the GPI transamidase complex and lead to accumulation of DKK1 free GPI anchor around the cell surface. Functional validation of the p.Asn383Lys variant was performed in a CHO cell line deficient for (Physique?S3). In order to analyze the phenotypic spectrum of the GPI transamidase deficiency and compare it to other GPIBDs, we conducted a systematic review of the phenotypic features of the most prevalent GPIBDs from the literature and additional cases with molecularly diagnosed GPIBDs (unpublished data). Therefore, we included individuals with mutations in (n = 26), (n = 10), (n = 5), and (n = 4, excluding two fetuses) for the GPI transamidase deficiencies; (n = 26) and (n = 28) for two types of hyperphosphatasia with mental retardation syndrome (HPMRS), HPMRS1 (MIM: 239300) and HPMRS3 (MIM: 615716), respectively; and (n?=?30; MIM: 606097) and (n = 54; MIM: 311770) for two types of.